Cartilage tissue engineering: adult human mesenchymal stromal cells and collagen biomaterials  by Sanjurjo-Rodríguez, C. et al.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S154Figure 3. Histology (Safranin O staining) of one unique SH clot sample
showing matrix formation surrounding cells (red stain) with evidence of
lacunae formation after 2 weeks in vivo.
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CARTILAGE TISSUE ENGINEERING: ADULT HUMAN MESENCHYMAL
STROMAL CELLS AND COLLAGEN BIOMATERIALS
C. Sanjurjo-Rodríguez y,z, A.H. Martínez Sanchez y,
T. Hermida-Gomez y, I.M. Fuentes y,z, J. Bujan x, F.J. De Toro z,
S. Díaz-Prado y,z, F.J. Blanco; y. y INIBIC- Univ. Hosp. of A Coru~na (CHUAC),
A Coru~na, Spain; z INIBIC Dept. of Med., Univ. of A Coru~na, A Coru~na, Spain;
xDept. of Med. Specialties, Univ. of Alcala de Henares, Madrid, Spain
Purpose: The purpose was to study chondrogenesis of adult human
Mesenchymal Stromal Cells, isolated from bone marrow (hBMSCs),
when culture on collagen (Col) biomaterials and to evaluate the suit-
ability of the neotissue formed to use in Tissue Engineering.
Methods: hBMSCswere culturedduring30days inchondrogenicmedium
with Transforming growth factor b-3 (TGFb-3) on the following bio-
materials: Col I, Col IþCol II, Col Iþ heparan sulphate (HS), Col IþCol IIþ
heparan sulphate (HS), Col IþCol IIþ chondroitin sulphate (CHS) and Col
Iþ heparin (OLH3).
We have tested growth and cell morphology on the constructs by histo-
chemical and Scanning (SEM) and Transmission (TEM) Electron Micro-
scopy. Chondrogenic differentiationwas evaluated in all the constructs by
histochemical and immunohistochemistry analyses and molecular biol-
ogy.Moreover, Col concentrationwasmeasured in supernatants along the
culture.
Results: Histology showed that hBMSCs have grown through the scaf-
folds, being the cell percentage respect to the total area of the scaffold:
>75% in Col I, Col IþCol II, Col IþHS, Col IþCol IIþHS, Col IþCol IIþCHS;<
50% in Col IþOLH3. It was observed a big amount of extracellular matrix
(ECM), except in Col IþOLH3. ECM from Col IþCol II and Col IþHS showed
the higher metachromasia for Safranin O proteoglycan staining, whereas
Col I, Col IþCol IIþHS, Col IþCol IIþCHS showed an intermediate meta-
chromasia (Figure). Col II immunostainingwas highly positive in Col I and
Col IþHS ECM and positive intracellularly in Col IþCol II, Col IþCol IIþ HS,
Col IþCol IIþCHS (Figure). Col IþOLH3 did not show positivity for pro-
teoglycans and Col II. By measurement of relative expression levels (REL),
COL II gene expression was seen in cells all over the biomaterials, Col I
(0.63 REL), Col IþCol II (1.00 REL), Col IþHS (0.47 REL), Col IþCol IIþHS
(0.93 REL), Col IþCol IIþCHS (3.57 REL) and Col IþOLH3 (5.20 REL). AGG
gene expressionwas higher in Col IþCol IIþHS (6.47 REL) constructs than
in Col I (0.00 REL), Col IþCol II (0.95 REL),Col IþHS (0.17 REL), Col IþCol
IIþCHS (0.00 REL) and Col IþOLH3 (0.00 REL). TEM analysis showed a bigamount of mitochondria and oval/rounded shape cells (Figure). We could
also see oval/rounded cells and ECM by SEM.
Col released (measured as mg/total volume) was detected in all the
supernatants, ﬁnding the highest concentration in Col IþHS biomaterials
cultures except at day 21: Col I (137.33), Col IþCol II (0.00), Col IþHS (0.00),
Col IþCol IIþHS (3.33), Col IþCol IIþCHS (13.90) and Col IþOLH3 (0.00).
Conclusions: Data showed hBMSCs are able to attach and proliferate on
all Col biomaterials, except in Col IþOLH3. These cells showed abundant
ECM. Analysis showed differentiated cellular phenotype and an ECM
similar to cartilage, inbiomaterials composedbyHS. Theneotissue formed
in the other biomaterials showed an intermediate phenotype. The neo-
tissue formed in Col and HS biomaterials could be useful for cartilage
tissue engineering. Acknowledgements: B. Parma (OPOCRIN S.P.A.); CAM
(S2009/MAT-1472); CIBER BBN CB06-01-0040; Red Gallega de Terapia
Celular (REDICENT); SAI-UDC; CSR is beneﬁciary of a fellowship from
Diputacion de A Coru~na; P. Esbrit (Fundacion Jimenez Díaz).
Figure: Images from the different constructs (columns). Ordered in rows
are shown the different analysis: Scanning (SEM) and Transmission (TEM)
Electron Microscopy, Safranin O staining (SO) and Collagen type II
immunostaining (Col II).
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MRI MORPHOLOGICAL AND QUANTITATIVE EVALUATION OF KNEE
ALLOGRAFT REPAIR AT 3, 6 AND 9 MONTHS POST-OP: EARLY
SURVEILLANCE DEMONSTRATES NASCENT PHYSIOLOGICAL
INCORPORATION OF ALLOGRAFT MATERIAL IN PAIN FREE PATIENTS
J.M. Farber y, B. Holladay z, J. Tamez-Pena x, S. Totterman k, E. Brandser y,
K. Baum k. yQmetrics, Cincinnati, OH, USA; zCommonwealth Orthopaedic
Ctr.s, Edgewood, KY, USA; x Tec de Monterry, Monteryy, Mexico; kQmetrics,
Rochester, NY, USA
Purpose: 1) Morphologically and quantitatively characterize the
appearance and incorporation of allograft material in patients who
are status-post knee articular cartilage (AC) allograft repair; 2) Compare
the characterizations in patients who are pain free with those who
are not.
Methods: Patients undergoing knee AC allograft (Biocartilage) procedures
at our institution receive follow-up MRIs Q three months. All patients are
scanned at 1.5 T (:450W, GE) with a dedicated 8 channel knee coil. Mor-
phological sequences include sagittal 2D PD FSFSE, 3D PD FS FSE and
coronal FSEIR.Quantitative sequences includemulti-echoand two-echoT2
Mapping. In addition, the 3D PD FS FSE sequences are segmented (Qme-
trics), and 3D thickness maps are rendered from the segmented data sets.
The morphological images are assessed for allograft ﬁll, bony edema,
osteophyte formationand the stabilityand integrityof theadjacentAC.The
quantitative data sets are evaluated to assess the degree on allograft
incorporation, speciﬁcally to determine the extent to which the allograft
material has T2 and thickness map values similar or not to the native
cartilage. These results are then correlated with each patient’s pain score
and function. Thus far, eightpatients havehadninemonth follow-upMRIs.
Results: Thus far, all patients’ allografts (N ¼ 8) show good ﬁll morpho-
logically at 3 months; the T2 Map values of the allografts at 3 months all
have higher values relative to the native cartilage - even if the adjacent
native cartilage is diseased - which indicates lower collagen and matrix
organization. At three months, the thickness maps demonstrate good
allograft ﬁll. All patients thus far studied have improved pain scores and
function relative to their pre-operative status. At 6 months, the morpho-
logical and thickness map data show improved allograft ﬁll, with
